<DOC>
	<DOCNO>NCT01605851</DOCNO>
	<brief_summary>The primary objective study evaluate clinical success performance GORE® Septal Occluder use percutaneous , transcatheter closure Patent Foramen Ovale ( PFO ) .</brief_summary>
	<brief_title>GORE® Septal Occluder European Union Clinical Evaluation</brief_title>
	<detailed_description />
	<criteria>Subjects PFO le equal 17mm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>PFO</keyword>
	<keyword>closure</keyword>
</DOC>